ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Live Donor Liver Transplantation With Older (>50years) Vs Younger (<50years) Donors: Does Age Matter?

    N. Goldaracena, G. Sapisochin, J. Echeverri, M. Kaths, N. Selzner, M. Cattral, P. Greig, L. Lilly, I. McGilvray, G. Levy, A. Ghanekar, E. Renner, D. Grant, M. Selzner.

    Multi Organ Transplant Program, Toronto General Hospital, Toronto, ON, Canada.

    Introduction: The risks of living donor liver transplantation (LDLT) with older donors remains controversial and many centers avoid using live donors ≥45 years of age.…
  • 2015 American Transplant Congress

    miRNA-181 Promotes Graft Prolongation by Plasmacytoid Dendritic Cells By Increasing T Regulatory Cells and Decreasing B Cells as Revealed By Cytometry By Time-Of-Flight

    A. Lau,1,2 M. Vitalone,1 X. Qu,1 T. Shawler,1 O. Martinez,1 C. Esquivel,1 S. Krams.1

    1Surgery, Stanford University, Stanford, CA; 2Pediatrics, UCSF, San Francisco, CA.

    Liver allografts are well tolerated and other solid organ allografts, when transplanted concurrently with livers, show improved outcomes. However, the mechanisms underlying “hepatic tolerance” have…
  • 2015 American Transplant Congress

    Application of Second Generation Sequencing and AlloAntibody Screening to the Organ Transplantation Arena

    B. Keating,1 Y. Li,1 K. Olthoff,1 J. Wang,2 A. Shaked.1

    1Surgery (Division of Transplantation), University of Pennsylvania, Philadelphia, PA; 3Genomics, BGI, Shenzhen, China.

    Over the last two decades, over 300,000 solid organ transplantations have been performed in the USA alone. While there has been considerable progress with immunosuppression…
  • 2015 American Transplant Congress

    Adverse Events of Maintenance Immunosuppression Following Kidney Transplantation Reported in Randomized Controlled Trials: A Systematic Review

    M. Howell,1,2 R. Yeo,2 A. Tong,1,2 J. Craig,1,2 K. Howard,2 G. Wong.2,3

    1Centre for Kidney Research, The Children's Hospital at Westmead, Westmeand, NSW, Australia; 2School of Public Health, University of Sydney, Sydney, NSW, Australia; 3Centre for Transplant and Renal Research, Westmead Hospital, Westmead, NSW, Australia.

    Aim: To evaluate the completeness of reporting of adverse events in randomized controlled trials (RCTs) of maintenance immunosuppression in kidney transplantation.Background: Side effects of maintenance…
  • 2015 American Transplant Congress

    Relationship Between Delayed Graft Function (DGF) Severity and Predicted DGF Risk

    E. Squiers,1 B. Irish,1 D. Odenheimer,1 S. Erlich,1 J. Grinyo, S. Feng, On Behalf of Quark DGF Study Investigators.

    1Quark, Fremont; 2UCSF, SF; 3U of Barcelona, BCN, Spain.

    Historically, dialysis required in the first post-transplant (TX) week has defined DGF. This incidence-based definition fails to discriminate between short versus long courses of dialysis…
  • 2015 American Transplant Congress

    Organ Procurement Organization Level Changes in Liver Utilization After Share-35

    E. Chow, A. Massie, X. Luo, A. Muzaale, D. Segev.

    Dept of Surgery, Johns Hopkins, Baltimore, MD.

    The OPTN implemented Share-35 in June 2013 to increase regional sharing. Organ Procurement Organization (OPO)-level changes in utilization subsequent to Share-35 have not previously been…
  • 2015 American Transplant Congress

    Effect of Intrapatient Variability and Mean Tacrolimus Levels in Renal Transplant Patients

    D. Goodall, M. Willicombe, A. McLean, D. Taube.

    Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.

    IntroductionNonadherence (NA) to immunosuppressive medication and adherence to immunosuppressive protocols is a potent risk factor for rejection and graft loss, which can be both patient…
  • 2015 American Transplant Congress

    B-Cell Tolerance to Donor Alloantigens

    A. Patil, M. Climov, A. Matar, A. Musa, E. Harrington, D. Sachs, R. Duran-Struuck, C. Huang.

    Department of Surgery, Transplantation Biology Research Center, Massachusetts General Hospital, Boston, MA.

    Pre-existing panel-reactive antibodies and development of donor-specific alloantibodies are known to play important roles in graft dysfunction and deterioration. Preventing and/or eliminating alloantibody responses would…
  • 2015 American Transplant Congress

    Increased Precentage of Circulating CD16+ Monocytes Before Transplantation Are Associated With the Occurence of Acute Rejection

    T. van den Bosch,1 L. Hilbrands,2 M. Kraaij,1 E. Vereyken,1 P. Leenen,3 D. Hesselink,1 C. Baan,1 A. Rowshani.1

    1Department of Internal Medicine, section Nephrology and Kidney Transplantation, Erasmus Medical Center, Rotterdam, Netherlands; 2Department of Nephrology, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands; 3Department of Immunology, Erasmus Medical Center, Rotterdam, Netherlands.

    Introduction: Monocytes compose a neglected immune cell type in transplantation despite their contribution to antibody mediated rejection. We aimed to define the phenotypic and functional…
  • 2015 American Transplant Congress

    Clinicopathological Scenarios (CPS) Defined by Viremia, Creatinine and Histology in Polyomavirus Nephropathy Differ in 1st and 2nd (Follow-Up) Biopsy

    C. Drachenberg, M. Chaudhry, F. Yang, R. Ugarte, A. Haririan, M. Mavanur, C. Cangro, B. Thomas, N. Costa, E. Ramos, M. Weir, J. Papadimitriou.

    Pathology and Medicine, University of Maryland School of Medicine, Baltimore, MD.

    Studies of sequential kidney biopsies (KB) after the diagnosis of polyomavirus allograft nephropathy (PVN) are scarce and clinicopathological evolution of PVN poorly understood. In practice…
  • « Previous Page
  • 1
  • …
  • 106
  • 107
  • 108
  • 109
  • 110
  • …
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences